Mindbody Inc stock has rapidly rising large players volume on an insider buy from Luxor Capital Group (major shareholder). Luxor Capital Group bought 83,022 shares at $27.95 for a total value of $2,320,464.90. You can see the SEC form 4 filing here.
Mindbody Inc. is a provider of cloud-based business management software for the wellness services industry (yoga, Pilates, barre, indoor cycling, personal training, martial arts and dance exercise, as well as spas, salons, music instruction studios, dance studios, childrens activity center and integrative health centers) and operates as a consumer marketplace with local business subscribers on its platform. The Company’s subscribers provide a range of wellness services to active consumers. Its integrated software and payments platform helps business owners in the wellness services industry run, market and build their businesses.
The company is growing revenue nicely.
That’s great upward momentum for Mindbody’s cloud services and I think there’s potential for new, high margin revenue streams as the company expands its dynamic cloud services platform.
Mindbody offers marketing, onling booking, retention, point of sale, client tools, staff resources, reports, apps, and automation. You can find out more about the company on their website here.
I really like Mindbody’s price point. A business with tight margins in the wellness services industry can have all of Mindbody’s tools to run their business for just $290 a month. That’s really affordable and makes Mindbody Inc the cloud-service to use for any wellness service company.
Mindbody Inc Stock
Large players volume is headed up nicely and the Twiggs Money Flow has gone positive.
Prices have been consolidating lately and the volatility has been reduced. There is a resistance zone just above the current price starting at $28.01. Right above this resistance zone may be a good entry point. There is a support zone below the current price at $27.99, a stop order could be placed below this zone.
Mindbody Inc Review
MB has a Piotroski-F score of 6. This indicates an average health and profitability for MB. MB has negative profitability ratios, so we won't be analyzing them here. MB's Return On Assets of -6.25% is worse than the rest of the industry. The industry average Return On Assets is -1.30%. MB's Profit Margin of -11.34% is worse than the rest of the industry. The industry average Profit Margin is -3.46%.
With a price book ratio of 4.86, MB is valued correctly. Compared to an average industry price book ratio of 4.57, MB is valued inline with its industry peers. The Price/Earnings Ratio is negative for MB. In the last year negative earnings were reported. Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MB. No positive earnings are expected for the next year.
The Earnings Per Share is expected to grow by 54.84% on average over the next 2 years. This is a very strong growth. The EPS growth is accelerating: in the next 2 years the growth will be better than in the last years. MB shows a strong growth in revenue. In the last year, revenue has grown by 33.24%. Revenue has been growing by 37.94% on average over the past 5 years. This is a very strong growth! The earnings per share for MB have decreased by -4.53% in the last year.
A Current Ratio of 9.28 indicates that MB has no problem at all paying its short term obligations. The Current Ratio of MB is much better than the industry average of 1.72. MB has better rating than 95% of its industry peers. MB has a Quick Ratio of 9.28. This indicates that MB is financially healthy and has no problem in meeting its short term obligations. The Quick Ratio of MB is much better than the industry average of 1.68. MB has better rating than 96% of its industry peers. MB has an Altman-Z score of 15.60. This indicates that MB is financially healthy and little risk of bankruptcy at the moment. MB has one of the better Altman-Z scores in its industry. It is much better than the industry average of 3.57. MB has better score than 91% of its industry peers. The Debt to Equity ratio of MB is inline with the industry averages. The Piotroski-F score of MB is 6. This is a neutral score and indicates average health and profitability for MB.
Latest posts by Lance Jepsen
- Sarepta Therapeutics In Strong Uptrend From Exondys 51 - November 19, 2017
- Top 16 Companies With Earnings and Revenue Beats - November 19, 2017
- Top Weekend News Stories November 19 2017 - November 19, 2017